Pfizer (PFE) Q1 2024 Earnings
PFE·Reported May 1, 2024·Before market open
Pfizer reported Q1 2024 revenue of $14.9B, beat analyst consensus of $13.9B by $1.0B. Diluted EPS came in at $0.82, beat the $0.52 consensus by $0.30. Pfizer reports across 2 business segments, led by Biopharmaceutical Products and Biosimilars.
Revenue
$14.9Bbeat by $1.0B
Consensus: $13.9BDiluted EPS
$0.82beat by $0.30
Consensus: $0.52
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Pfizer's Q1 2024 earnings report.
Pfizer (PFE) reported Q1 2024 earnings on May 1, 2024 before market open.
Pfizer reported revenue of $14.9B and diluted EPS of $0.82 for Q1 2024.
Revenue beat the consensus estimate of $13.9B by $1.0B. EPS beat the consensus estimate of $0.52 by $0.30.
You can read the 10-Q periodic report (0000078003-24-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.